Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Bérengère Gobin · SciRah

Researcher profile · Semantic Scholar

Bérengère Gobin

Share profile

Bérengère Gobin — researcher profile on SciRah

h-index: 6
Works: 12
Citations: 317

Most-cited papers

BYL719, a new α‐specific PI3K inhibitor: Single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma
Bérengère Gobin, Marc Baud' Huin, F. Lamoureux, B. Ory +7 more
2015International Journal of Cancer71 citations Open access
Semantic Scholar
NVP-BEZ235, a dual PI3K/mTOR inhibitor, inhibits osteosarcoma cell proliferation and tumor development in vivo with an improved survival rate.
Bérengère Gobin, S. Battaglia, Rachel Lanel, J. Chesneau +4 more
2014Cancer Letters67 citations
Semantic Scholar
Orthopaedic implant failure: aseptic implant loosening--the contribution and future challenges of mouse models in translational research.
L. Córdova, Verena Stresing, Bérengère Gobin, P. Rosset +5 more
2014Clinical science59 citations Open access
Semantic Scholar
Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models
Bérengère Gobin, G. Moriceau, B. Ory, C. Charrier +4 more
2014PLoS ONE50 citations Open access
Semantic Scholar
Therapeutic approach of primary bone tumours by bisphosphonates.
G. Moriceau, B. Ory, Bérengère Gobin, F. Verrecchia +4 more
2010Current pharmaceutical design38 citations
Semantic Scholar
Skeletal consequences of RANKL-blocking antibody (IK22-5) injections during growth: mouse strain disparities and synergic effect with zoledronic acid.
F. Lézot, J. Chesneau, Benjamin Navet, Bérengère Gobin +8 more
2015Bone33 citations
Semantic Scholar
mAbs targeting RANKL in bone metastasis treatment
F. Uçkun, Bérengère Gobin, M. Baud'huin, B. Isidor +2 more
20131 citations
Semantic Scholar
NVP-BEZ235, a dual PI3K/mTOR inhibitor, inhibits osteosarcoma cell proliferation and the tumor development in vivo
Bérengère Gobin, S. Battaglia, J. Chesneau, D. Heymann
20131 citations
Semantic Scholar
Over-expression of Smad7 in osteosarcoma cells inhibits primary tumor growth, the associated bone osteolysis and the development of lung metastasis in murine xenograft model
Audrey Lamora, Julie Talbot, Bérengère Gobin, Marion Leduc +5 more
20130 citations
Semantic Scholar
Therapeutic interest of Imatinib Mesylate in osteosarcoma
Bérengère Gobin, G. Moriceau, B. Ory, R. Brion +2 more
20130 citations
Semantic Scholar
New PI3K[alpha]-specific inhibitor, BYL719: therapeutic interest in osteosarcoma
Bérengère Gobin, C. Charrier, S. Hervouet, F. Lézot +2 more
20130 citations
Semantic Scholar
Approches thérapeutiques des ostéosarcomes par ciblage des activités kinases
Bérengère Gobin
20130 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Heymann×10
Invite
D. Heymann — researcher profile on SciRah
F. Redini×7
Invite
F. Redini — researcher profile on SciRah
B. Ory×5
Invite
B. Ory — researcher profile on SciRah
C. Charrier×3
Invite
C. Charrier — researcher profile on SciRah

×3

Invite

S. Battaglia — researcher profile on SciRah

Invite

F. Lézot — researcher profile on SciRah

F. Blanchard×3

Invite

F. Blanchard — researcher profile on SciRah

Invite

J. Chesneau — researcher profile on SciRah

Invite

G. Moriceau — researcher profile on SciRah

Invite

R. Brion — researcher profile on SciRah

Rachel Lanel×2

Invite

Rachel Lanel — researcher profile on SciRah

Invite

J. Amiaud — researcher profile on SciRah